Traing Source
Video: Compound Annual Growth Rate (CAGR) Definition

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Latest Articles

t rowe price dividend history at&t stock price history chart continental resources stock price history bank of ozarks stock quote bob evans stock price history sealed air stock price history stock price for gilead sciences fifth third bank stock history devon energy stock price history how much is ge stock colgate palmolive stock price history emc corp stock price history sirius xm stock price history price of exxon mobil stock historical procter and gamble stock prices newell rubbermaid stock price history american electric power stock dividend when does pfizer pay dividends intercontinental hotels share price today philip morris international stock quote stock symbol for anheuser busch harley davidson stock price chart price of exxon mobil stock historical crescent point energy stock price history johnson and johnson stock chart history of jpmorgan chase bank royal dutch shell stock price history stock quote for brk b stock price for duke energy stock price for coca cola today huntington bank stock price history
Date Open High Low Close Volume
01/12/2018 $44.53 $44.64 $41.55 $42.28 737.40K
01/16/2018 $41.86 $42.09 $40.73 $41.10 257.00K
01/17/2018 $41.90 $42.05 $41.07 $41.43 445.00K
01/18/2018 $42.87 $43.15 $42.11 $42.35 404.40K
01/19/2018 $42.22 $42.38 $41.25 $41.63 188.10K
Ablynx is a biopharmaceutical company. Through its subsidiary, Co. is engaged in the discovery and development of Nanobodies, a class of therapeutic proteins based on single-domain antibody fragments for a range of serious and life-threatening human diseases. Co. develops products for various disease areas, including inflammation, thrombosis, oncology, and pulmonary diseases. Its lead programmes include ALX-0081, an intravenously administered novel anti-thrombotic, is under Phase II clinical trials in patients undergoing percutaneous coronary intervention; and ALX-0681, an anti-thrombotic is under Phase II clinical trials in patients with thrombotic thrombocytopenic purpura.
ABLX historical stock prices picture
Ablynx (ABLX) has the following price history information. Looking back at ABLX historical stock prices for the last five trading days, on January 12, 2018, ABLX opened at $44.53, traded as high as $44.64 and as low as $41.55, and closed at $42.28. Trading volume was a total of 737.40K shares. On January 16, 2018, ABLX opened at $41.86, traded as high as $42.09 and as low as $40.73, and closed at $41.10. Trading volume was a total of 257.00K shares. On January 17, 2018, ABLX opened at $41.90, traded as high as $42.05 and as low as $41.07, and closed at $41.43. Trading volume was a total of 445.00K shares. On January 18, 2018, ABLX opened at $42.87, traded as high as $43.15 and as low as $42.11, and closed at $42.35. Trading volume was a total of 404.40K shares. On January 19, 2018, ABLX opened at $42.22, traded as high as $42.38 and as low as $41.25, and closed at $41.63. Trading volume was a total of 188.10K shares.

ABLX Historical Stock Prices By Date:

ABLX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ablynx shares, starting with a $10,000 purchase of ABLX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/25/2017
End date: 01/19/2018
Start price/share: $22.51
End price/share: $41.63
Dividends collected/share: $0.00
Total return: 84.94%
Annualized Gain: 360.50%
Starting investment: $10,000.00
Ending investment: $18,494.00
Years: 0.24
Date Close
ABLX is categorized under the Healthcare sector; below are some other companies in the same sector:

ABMD Historical Stock Prices
ABT Historical Stock Prices
ABUS Historical Stock Prices
ACAD Historical Stock Prices
ACER Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACHV Historical Stock Prices
ACIU Historical Stock Prices

ABLX Historical Stock Prices | | Copyright © 2013 - 2018, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following . Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; , and .